Discontinuation of SGLT2i After a Urogenital Infection: A Population-Based Matched Cohort Study of Patients With Type 2 Diabetes
Diabetes Obes Metab. 2026 Apr 14. doi: 10.1111/dom.70771. Online ahead of print.ABSTRACTAIMS: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) improve glycaemic control and cardiorenal outcomes in Type 2 diabetes, particularly in patients at elevated cardiovascular and kidney risk, yet discontinu

